Marti Farm became our official partner in the summer of 2019 and echoes the services, values and ethos that we offer in the field of drug, device and patient safety. Our relationship with Marti Farm will allow our clients to maintain licences in EU and the UK post Brexit.

We started talking to Marti Farm in 2015 when we were looking for an affiliate in the CEE – Central and Eastern Europe and South Western EU markets. After reciprocal visits, we realised that our businesses were mirror images of each other. Our companies both have highly qualified team members that are complimentary so we can enhance our businesses together.

Although we remain two companies, we are effectively one team. We made our relationship official and have started to work proactively together on projects across the globe.

Marti Farm was established in 2011 by founder and current CEO - Dr Martina Smetiško - and is based out of Zagreb with clients across the Adriatic, Russia and other Central and Eastern European countries.

Marti Farm are recognised as a reliable partner and provider of consultancy and regulatory services across pharmacovigilance, registration and market access, clinical trials, patient support programmes and medical writing.

At the time of writing this entry, here in the UK, we are not sure of the solution our new legislature will take. However, we have built the flexibility, strength and depth of knowledge in our workforce to be able to respond to whatever the outcome will be post-Brexit.

PDS and Marti Farm –two countries; two companies – ONE TEAM.